(Q37733550)

22 August 2017

1 reference

title

Oncolytic adenoviruses expressing interleukin: a novel antitumour approach (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

Dong-Sheng Pei

1

1 reference

22 August 2017

Jun-Nian Zheng

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

917-926

1 reference

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Overview of interleukin-2 function, production and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The dichotomous role of IL-2: tolerance versus immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin-2-dependent mechanisms of tolerance and immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Management of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin 18: tipping the balance towards a T helper cell 1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin-18 regulates both Th1 and Th2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Determinants of antileukemia effects of allogeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Is mda-7/IL-24 a "magic bullet" for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

mda-7/IL-24: exploiting cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

The role of the CD28 receptor during T cell responses to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

A Role for IL-18 in Neutrophil Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.481668

10.1517/14712598.2010.481668

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference